- Home
- RLAY vs REX Comparison
RLAY vs REX Comparison
Compare RLAY & REX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | REX |
|---|---|---|
| Founded | 2015 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | RLAY | REX |
|---|---|---|
| Price | $9.59 | $47.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | $16.86 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 2.5M | 162.7K |
| Earning Date | 05-04-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.78 | N/A |
| EPS | N/A | ★ 1.18 |
| Revenue | $15,355,000.00 | ★ $642,491,000.00 |
| Revenue This Year | N/A | $3.27 |
| Revenue Next Year | $324.03 | $17.11 |
| P/E Ratio | ★ N/A | $37.38 |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $1.78 | $30.02 |
| 52 Week High | $11.49 | $64.95 |
Technical Indicators
Market Signals| Indicator | RLAY | REX |
|---|---|---|
| Relative Strength Index (RSI) | 49.08 | 81.63 |
| Support Level | $9.06 | $31.24 |
| Resistance Level | $11.46 | $55.35 |
| Average True Range (ATR) | 0.63 | 1.82 |
| MACD | -0.12 | 0.54 |
| Stochastic Oscillator | 16.18 | 97.23 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About REX REX American Resources Corporation
REX American Resources Corp operates as a holding company, which engages in investment in alternative energy and ethanol production entities. Its operating segments include Ethanol and By-Products. Its products include dried distillers grains, modified distillers grains, and non-food grade corn oil.